Bolt Biotherapeutics Ownership | Who Owns Bolt Biotherapeutics?


OverviewForecastRevenueFinancialsChart

Bolt Biotherapeutics Ownership Summary


Bolt Biotherapeutics is owned by 7.86% institutional investors, 7.10% insiders, and 85.03% retail investors. Sofinnova investments is the largest institutional shareholder, holding 7.37% of BOLT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.46% of its assets in Bolt Biotherapeutics shares.

BOLT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBolt Biotherapeutics7.86%7.10%85.03%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Sofinnova investments137.72K7.37%$556.39K
Renaissance77.22K4.13%$311.99K
Vivo capital72.41K3.87%$292.55K
Tang capital management66.88K3.49%$355.80K
Samsara biocapital48.83K2.55%$259.78K
Pivotal bioventure partners investment advisor42.58K2.28%$172.03K
Board of trustees of the leland stanford junior university35.98K1.92%$145.35K
Pfizer31.30K1.67%$137.12K
Lynx1 capital management lp30.80K1.65%$124.43K
Nan fung group29.25K1.56%$118.17K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nano cap new millennium growth fund l p27.50K0.10%$111.10K
Nan fung group29.25K0.10%$118.17K
Pivotal bioventure partners investment advisor42.58K0.06%$172.03K
Pfizer31.30K0.06%$137.12K
Samsara biocapital48.83K0.03%$259.78K
Vivo capital72.41K0.02%$292.55K
Sofinnova investments137.72K0.02%$556.39K
Lynx1 capital management lp30.80K0.02%$124.43K
Board of trustees of the leland stanford junior university35.98K0.02%$145.35K
Tang capital management66.88K0.01%$355.80K

Top Buyers

HolderShares% AssetsChange
Lynx1 capital management lp30.80K0.02%30.80K
Renaissance77.22K0.00%22.20K
Blackrock267.07K-12.11K
Susquehanna group, llp11.66K-11.66K
Citadel advisors10.11K-10.11K

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---1.54M
Acuitas investments---630.51K
Adage capital partners gp---500.00K
Newtyn management---468.91K
Marquette asset management---113.80K

New Positions

HolderShares% AssetsChangeValue
Lynx1 capital management lp30.80K0.02%30.80K$124.43K
Citadel advisors10.11K-10.11K$40.84K
Vanguard fiduciary trust3.10K-3.10K$12.50K
Vanguard global advisers24.00-24.00$97.00

Sold Out

HolderChange
Bnp paribas arbitrage, snc-1.00
Qube research-2.00
Salem investment counselors-2.00
Fmr-121.00
Wells fargo & company/mn-211.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20269-57.14%147,058-75.59%70.80%5-28.57%--100.00%
Dec 31, 202517-29.17%550,535-31.53%281.63%6-14.29%2-75.00%
Sep 30, 2025244.35%804,036-9.28%41784.60%7250.00%8-61.90%
Jun 30, 202524-14.29%889,879-95.14%240.64%2-80.00%22340.00%
Mar 31, 202528-24.32%18,325,858-1.84%472.01%10-41.18%5-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv47.18K2.46%-1.03K
Vanguard US Total Market Shares ETF861.87K2.25%-1.00
Fidelity Extended Market Index17.12K0.89%8.49K
Vanguard Institutional Extnd Mkt Idx Tr7.06K0.37%-
PGIM US Micro Cap Quant Equity5.78K0.30%-
Fidelity Total Market Index5.35K0.28%-
NT Ext Equity Mkt Index Fund - Lending5.01K0.26%-
NT Ext Equity Mkt Idx Fd - L5.01K0.26%-
Fidelity Enhanced Small Cap ETF90.25K0.24%1.69K
Spartan Extended Market Index Pool F3.19K0.17%38.00

Recent Insider Transactions


DateNameRoleActivityValue
Dec 05, 2025Quinn William P. President, CEO and CFOBuy$575.88
Dec 05, 2025Nemec Sarah Senior VP, Finance and PAOBuy$575.88
Jun 06, 2025Nemec Sarah Senior VP, Finance and PAOBuy$686.50
Jun 06, 2025Quinn William P. President, CEO and CFOBuy$686.50
Dec 16, 2024Nemec Sarah Senior VP, Finance and PAOBuy$1.24K

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q22-
2024 Q42-
2024 Q3--
2024 Q2--

BOLT Ownership FAQ


Who Owns Bolt Biotherapeutics?

Bolt Biotherapeutics shareholders are primarily institutional investors at 7.86%, followed by 7.10% insiders and 85.04% retail investors. The average institutional ownership in Bolt Biotherapeutics's industry, Biotech Stocks , is 35.75%, which Bolt Biotherapeutics falls below.

Who owns the most shares of Bolt Biotherapeutics?

Bolt Biotherapeutics’s largest shareholders are Sofinnova investments (137.72K shares, 7.37%), Renaissance (77.22K shares, 4.13%), and Vivo capital (72.41K shares, 3.87%). Together, they hold 15.37% of Bolt Biotherapeutics’s total shares outstanding.

Does Blackrock own Bolt Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of Bolt Biotherapeutics.

Who is Bolt Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Nano cap new millennium growth fund l p is Bolt Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 0.10% of its assets in 27.5K Bolt Biotherapeutics shares, valued at 111.1K$.

Who is the top mutual fund holder of Bolt Biotherapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Bolt Biotherapeutics shares, with 2.46% of its total shares outstanding invested in 47.18K Bolt Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools